Objective 2 Discuss recent data, guidelines, and counseling points pertaining to the older adults with diabetes.

Slides:



Advertisements
Similar presentations
Katee Lira, PharmD PGY2 Ambulatory Care Pharmacy Resident
Advertisements

Diabetes in Pregnancy Screening.
Disability, Frailty and Co-morbidity Gero 302 Jan 2012.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Diabetes Disabilities Dr Abeer Al-Saweer. Lecture Layout Definition of Disabilities Spectrum of Disabilities Diabetes and Disabilities Factors related.
Barriers to Diabetes Control Mark E. Molitch, MD.
LONG TERM BENEFITS OF ORAL AGENTS
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.
Diabetes in the 21 st Century 2010 Update. American Diabetes Association 2010 Guidelines – Diagnostic Criteria A1C > or = 6.5% is included as diagnostic.
Diabetes in Elderly Adults. By the age of 75, approximately 20% of the population are afflicted with this illness.. By the age of 75, approximately 20%
Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University
CARE OF PATIENTS WITH DIABETES MELLITUS JANNA WICKHAM RN MSN LSSC FALL 2013 Chapter 20.
Nursing Care of Clients with Diabetes Mellitus.
Criteria for the diagnosis of DM Symptoms of diabetes plus random blood glucose concentration ≥ 200 mg/dl OR FPG ≥ 126 mg/dl OR Two –hour plasma glucose.
PHARMACOLOGICAL THERAPY FOR TYPE 2 DIABETES Reyhane Azizi M.D Assistant Prof. of Endocrinology and Metabolism Shahid Sadoghi University of Medical Sciences.
Shadi Al-Ahmadi. The Presentation will include: Hypertension Dyslipidemia CVD Type 2 Diabetes-Associated Retinopathy Diabetic Periphral Neuropathy Diabetic.
Incremental Decrease in Clinical Endpoints Through Aggressive Lipid Lowering (IDEAL) Trial IDEAL Trial Presented at The American Heart Association Scientific.
Diabetes Therapy in the Elderly Epidemiology –>20% of patients over 65 have DM2 –10% of diabetes cases are diagnosed after the age of 65 Research and Evidence.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
Critical Appraisal Did the study address a clearly focused question? Did the study address a clearly focused question? Was the assignment of patients.
DIABETES IN THE ELDERLY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Diabetes Mellitus 101 for Medical Professionals An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes: Stan Schwartz MD,FACP.
Therapy of Type 2 Diabetes Mellitus: UPDATE
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Oral Diabetes Medications Carol Cordy, MD. Goals Understand how type 2 diabetes affects many organs and how this changes over the course of the illness.
Therapy for Type II Diabetes. Non-Insulin Therapy for Hyperglycemia in Type 2 Diabetes, Match Patient Characteristics to Drug Characteristics 5. Gut.
Chapter Exercise and Diabetes Dixie L. Thompson C H A P T E R.
Type 2 diabetes mellitus in the older patient Shokoufeh Bonakdaran Associate Professor of Endocrinology Mashhad university of medical sciences.
Who is considered elderly? “Young old” years “Old, old” >75 years.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
Do Now (no sheet today) Pick up a laptop for yourself Open school website.
Strategies to Reduce Hypoglycemia Presented by: Hennie Garza, M.S., R.Ph., C.D.E, Director of Pharmacy Utilization and Outcomes Senior Care Centers
Angela Aziz Donnelly April 5, 2016
Guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association CHOICE OF AGENT AFTER INITIAL METFORMIN.
R1. 이정미 / prof. 이상열. INTRODUCTION Type 2 diabetes is a major risk factor for cardiovascular disease The presence of both type 2 diabetes and.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Screening System for Hypertension and Diabetes at Primary Care Level
Diabetes Learning Event 7th October 2016
CHANGES in ada 2015.
Management of Diabetes in the Older Person
Nephrology Journal Club The SPRINT Trial Parker Gregg
ACCORD Design and Baseline Characteristics
2012 ADA Clinical Practice Guidelines Therapies for DM- Type 2
Reducing Adverse Outcomes after ACS in Patients with Diabetes Goals
Hypertension JNC VIII Guidelines.
Treatment algorithm for management of type 2 diabetes mellitus
Recommendation In people with clinical cardiovascular disease in whom glycemic targets are not met, a SGLT2 inhibitor with demonstrated cardiovascular.
Diabetes Mellitus Nursing Management.
Care of Patients with Diabetes Mellitus
Neal B, et al. Diabetes Care 2015;38:403–411
The Anglo Scandinavian Cardiac Outcomes Trial
Diabetes Health Status Report
Management of Diabetes in the Older Person
Macrovascular Complications Microvascular Complications
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Clinical Advances in Type 2 Diabetes and Cardiovascular Risk
Antihyperglycemic therapy in type 2 diabetes: general recommendations.
Common Health Problems of Older Adults
RCHC’s Cardiovascular Health Initiative
Antihyperglycemic therapy in type 2 diabetes: general recommendations.
Chapter 26 Endocrine Function
Pharmacological Treatment of Hypertension Update 2012
Case 1: A 78-year-old white female with hypertension and hyperlipidemia Discussion Points: In that this patient has documented atherosclerotic vascular.
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Hyperglycemic Targets & Hypoglycemia
Fig. 1. Antihyperglycemic therapy algorithm for adult patients with type 2 diabetes mellitus (T2DM). The algorithm stratifies the choice of medications.
Many post-MI patients are not receiving optimal therapy
POLYPHARMACY.
Presentation transcript:

Objective 2 Discuss recent data, guidelines, and counseling points pertaining to the older adults with diabetes.

Special Considerations Poorer socioeconomic situation Greater social isolation and loneliness Nursing home residency Polypharmacy Increases the risk of drug side effects and drug-to-drug interactions Higher frequency of depressive illness or cognitive impairment Alzheimer’s-type and multi-infarct dementia are approximately twice as likely to occur in those with diabetes Untreated depression Difficulty with selfcare Implementing healthier lifestyle choices Higher risk of mortality

Special Considerations Decreased Renal & Hepatic Function Increased risk of adverse drug events Increased risk of hypoglycemia Increased risk of under treating hyperglycemia Presence of a geriatric syndrome: confused state, depression, falls, incontinence, immobility, pressure sores Presence of disabilities resulting from lower-limb vascular disease or neuropathy requiring a rehabilitation program Frailty and limited life expectancy

ADA Guidelines Treatment goals for older adults are the same as younger adults if they have: 1. Physical and cognitive functionality 2. Adequate life expectancy to see the benefits May widen glycemic goals if individual criteria is not met in older adults Caution: avoid hyperglycemia-related complications American Diabetes Association. Standards of medical care in diabetes—2012. Diabetes Care. 2012;35(suppl 1):S11-S63.

ADA Guidelines Treat cardiovascular risk factors according to individual patient characteristics Hypertension treatment in older adults shows value in clinical trials Lipid and aspirin therapy should be considered in older adults with diabetes if their life expectancy within the time period of the primary and secondary prevention trials Monitor for complications, especially ones that lead to functional impairment Individualize screening schedules Yearly foot exams and podiatrist visits American Diabetes Association. Standards of medical care in diabetes—2012. Diabetes Care. 2012;35(suppl 1):S11-S63.

ADA Guidelines Metformin and lifestyle changes should be initiated at diagnosis Contraindications to starting metformin: Renal impairment with SCr ≥ 1.5mg/dL in males or ≥ 1.4mg/dL in females Severe liver impairment Acute or chronic metabolic acidosis (including DKA) Undergoing radiographic dye studies Hypoxemia Sepsis CHF American Diabetes Association. Standards of medical care in diabetes—2012. Diabetes Care. 2012;35(suppl 1):S11-S63.

ADA Guidelines Insulin therapy should be considered at initial diagnosis, +/- oral agents, when patients are symptomatic with or without increased glucose levels or A1C Second oral agent or insulin therapy can be added if noninsulin monotherapy is at max dose and is failing to achieve A1C goal over 3-6 months. American Diabetes Association. Standards of medical care in diabetes—2012. Diabetes Care. 2012;35(suppl 1):S11-S63.

ADA Guidelines Treat CV risk factors while considering: Timeframe of benefit, individual patient characteristics Hypertension treatment indicated in many older adults Lipid lowering and aspirin therapy may benefit patients whose live expectancy is equal to timeframe of primary or secondary prevention trials   Individualize screening for complications that may lead to functional impairment Age >64 is a high-priority population for depression screening and treatment and diabetes can make this condition worse American Diabetes Association. Standards of medical care in diabetes—2012. Diabetes Care. 2012;35(suppl 1):S11-S63.

Clinical Pearls Considerations about specific pharmacologic therapy in older adults: Insulin requires good visual, motor, and cognitive skills Metformin is contraindicated in renal insufficiency and significant heart failure TZDs can cause fluid retention may exacerbate or lead to heart failure Sulfonylureas can cause hypoglycemia DPP-4 Inhibitors may increase risk of heart failure hospitalization SGLT-2 inhibitors may increase UTI and frequency of urination American Diabetes Association. Standards of medical care in diabetes—2012. Diabetes Care. 2012;35(suppl 1):S11-S63.

Hypoglycemia in Elderly Hypoglycemia in elderly = increased risk of falls due to dizziness Hypoglycemia in elderly can be masked if patient is also taking a beta-blocker. Mask symptoms except sweating If insulin dependent and trouble with hands or vision, difficulty accurately drawing up correct amount of insulin. Too much = hypoglycemia Hypoglycemia counseling Glucose tablets

Counseling Points Importance of taking their medications Side effects Signs/Symptoms of hypoglycemia See Podiatrist each year Update vaccinations American Diabetes Association. Standards of medical care in diabetes—2012. Diabetes Care. 2012;35(suppl 1):S11-S63.